Actress Busy Philipps disclosed this week that a full-body MRI she booked after her own physician told her she was too healthy to need one found a brain tumor she had no symptoms of. Two operations later, she told People that she is grateful to be alive and described the past half year as the strangest of her life.
The scan was done in February. It flagged a lesion, follow up imaging confirmed a tumor in her frontal lobe, and on March 2 a five hour operation removed a 2.6 centimeter grade 2 oligodendroglioma. In April, a dermatologist noticed the incision looked wrong during a Botox appointment and refused to proceed. That led to a staph infection diagnosis and a second operation on April 27 to clean the site and remove one of the small titanium tacks placed in her skull during the first procedure.
The story will send people to booking pages, and that is where the coverage tends to stop. The more useful question for readers is what these scans actually do for a person with no symptoms, because the answer is genuinely mixed and the professional bodies that set imaging standards have not endorsed them.
The Tumor and the Two Operations
Oligodendroglioma is a tumor of the glial cells that support the nervous system. Philips' neuro-oncologist told People that it carries the best prognosis of all the malignant gliomas, and explained that it is classified as cancerous because of its tendency to regrow slowly over time rather than because of how aggressive it looks under a microscope.
Grade 2 means slow-growing. Slow-growing also means quiet, which is why a tumor of this size can sit in the frontal lobe without producing the headaches, seizures, or personality changes people associate with brain tumors. Her doctors told People that waiting until symptoms such as seizures appeared could have allowed the tumor to grow to two or three times its size.
Treatment for these tumors typically pairs surgery with long-term surveillance imaging, and radiation or chemotherapy may be added depending on how much was removed, the molecular profile, and whether the tumor returns. Philipps does not currently need either, but she faces scheduled monitoring scans going forward. Surgery is not the end of the process.
The infection is worth noting separately. Surgical site infections after craniotomy are uncommon but not rare, and hers was caught because a clinician in an unrelated appointment looked at the incision and stopped.
The Case for and Against Scanning Healthy People
Commercial full-body MRI has grown into a fee-for-service industry marketed directly to consumers. The scans use no radiation, take under an hour, and are advertised as checking for hundreds of conditions across dozens of organs. They run into the thousands of dollars, are generally not covered by insurance, and require no referral.
The American College of Radiology concluded that there is insufficient evidence to justify recommending total body screening for people without symptoms, risk factors or a family history suggesting disease, and stated that no documented evidence shows the practice is cost efficient or effective in prolonging life. The society's position has not changed as the market has expanded.
The strongest counterargument is not about healthy people in general. It is about specific gaps. Several cancers, including pancreatic, kidney, and ovarian, have no recommended screening test for average-risk adults. Whole-body MRI is recommended for people with hereditary cancer predisposition syndromes such as Li-Fraumeni syndrome, where the pretest probability is high enough to change the math entirely.
Numbers Behind the Incidental Finding Problem
The core issue is not whether these scans find things. It is what proportion of what they find matters.
A review of 12 studies cited by Fred Hutch Cancer Center found that 95 percent of asymptomatic people had at least one abnormal finding on a whole-body MRI performed for cancer screening, and that 91 percent of those findings were not clinically relevant. Radiologists at Fred Hutch and UW Medicine do not offer the exam and will not reinterpret outside whole-body MRIs. In published studies, the cancer detection rate in adults is roughly one to two percent, and whether those cancers would ever have caused a problem is unknown.
They also flag a technical limitation that surprises people. The breast portion of a typical commercial whole-body scan is done with the patient on her back and without intravenous contrast, both of which the American College of Radiology requires for accredited breast MRI. A scan that covers everything is not equivalent to a dedicated study of any one thing.
Each irrelevant finding still generates follow-up. Additional imaging, specialist visits, sometimes biopsies, and the anxiety that runs alongside all of it. For most people, the scan produces ambiguity rather than reassurance. For a small number, as in this case, it produces a diagnosis that genuinely changed the outcome. Both are true, and which one a given person gets is not knowable in advance.
Questions Worth Asking Before Booking a Scan
Nobody should read a celebrity disclosure as a screening recommendation, and nobody should read this article as a reason to cancel a scan they have already decided on with a clinician. The reasonable middle is to go in informed.
Anyone considering one can ask what happens if the scan finds something ambiguous, who interprets the images and what their subspecialty training is, whether results will be sent to a primary care doctor, and what the follow-up will cost given that insurance generally will not pay for the workup of an incidental finding either.
The screenings with proven mortality benefit remain the unglamorous ones. Colonoscopy or stool-based testing, mammography, cervical cancer screening, lung cancer screening for people with significant smoking history, and blood pressure and cholesterol checks. People with a strong family cancer history should ask about genetic counseling, which can identify the situations where whole-body MRI actually is indicated.
Symptoms are a different matter entirely. Persistent headaches that change in pattern, new seizures, unexplained weakness or numbness on one side, vision changes, or personality or memory changes warrant medical evaluation regardless of any screening decision. Age is not a reliable filter either, as the case of a childhood brain tumor found in an older adult showed earlier this month.
Key Questions Answered
What did Busy Philipps disclose? That a full-body MRI in February found a brain tumor she had no symptoms of, that a five-hour operation on March 2 removed a 2.6-centimeter grade 2 oligodendroglioma, and that a second operation on April 27 treated a staph infection at the surgical site.
What is an oligodendroglioma? A tumor arising from glial cells in the central nervous system. Her neuro-oncologist said it carries the best prognosis among malignant gliomas and is classified as cancerous mainly because it can regrow slowly.
Do radiology groups recommend full body MRI for healthy people? No. The American College of Radiology found insufficient evidence to recommend total-body screening in people without symptoms, risk factors, or relevant family history, and noted no documented evidence that it prolongs life.
What is the incidental finding problem? In a review of 12 studies, 95 percent of asymptomatic people had at least one abnormal finding, and 91 percent of those were not clinically relevant. Each still tends to generate follow-up testing.
Is there anyone the scans are recommended for? People with hereditary cancer predisposition syndromes, where whole-body MRI appears in formal guidelines. Genetic counseling is the route to knowing whether that applies.
Does insurance cover these scans? Generally not, and typically not the follow-up workup of an incidental finding either. The full cost, including downstream testing, is worth asking about upfront.
What brain symptoms need evaluation? New or changing headaches, seizures, one-sided weakness or numbness, vision changes, and shifts in personality or memory should be assessed by a clinician regardless of any screening decision.
